Skip to main content
. 2019 Aug 13;27(6):540–552. doi: 10.4062/biomolther.2019.027

Fig. 4.

Fig. 4.

Cell phase analysis of HepG2 treated with ITCs at 40 μM for 12 h; cells in G1, S, and G2/M phase (A), and flow cytometry histogram (B). Results expressed as mean ± SD (n=3).